Objective: To examine whether needle exchange program (NEP) use by injecting drug users (IDUs) affects injection risk behaviors over time.
S
haring of needles and other paraphernalia for illicit drug injection is a major mode of transmission for HIV and other bloodborne pathogens. In the United States, injection drug use is the second most common means of HIV infection for men and women 1 and the principal transmission route for hepatitis C virus. 2 Needle exchange programs (NEPs) attempt to prevent HIV transmission by providing new sterile needles in return for used needles. Many NEPs also address HIV risk practices by offering educational and behavioral interventions, other HIV prevention supplies, and referrals to services such as drug treatment programs. 3 Although the preponderance of evidence indicates that NEPs are effective in reducing needle sharing, 4-11 the findings are not entirely consistent. In their review of the effectiveness of NEPs, Gibson and colleagues 4 found that 28 studies reported beneficial effects on HIV seroconversion or risk behaviors, whereas 16 reported no association or some detrimental effects. The authors attributed these inconsistencies to variations in study design and settings. Foremost, studies that found neutral or negative effects recruited samples from a single injection drug user (IDU) community, an approach subject to serious selection and dilution biases. 4 Selection bias occurs because IDUs who enroll in NEPs, compared with other IDUs in the same community, tend to be more socially marginalized and more frequent injectors and exhibit higher levels of risk behaviors before initiating NEP use. [12] [13] [14] [15] [16] Comparisons of risky and less risky IDUs are likely to mask the benefits that any intervention may confer on the former. Dilution bias has 2 sources. First, NEP nonattenders may obtain clean needles directly or indirectly from attenders. Second, nearly all studies that reported no or negative associations between NEP use and risk behavior or HIV incidence were conducted in settings in which needles were legally available at low cost without a prescription. 4 Dilution bias likely resulted in NEP users and nonusers having approximately equal access to sterile needles. 4, 17 In addition to these problems, most studies of NEP use in the United States have used cross-sectional designs, 4 which limit the ability to attribute cause and effect, or short-term longitudinal designs, which leave open the question of longterm impact. Some studies lacked control groups, which limits their ability to separate NEP effects from temporal trends that occurred 18, 19 as IDUs responded to the AIDS epidemic. The current study addressed these issues: it was conducted in Chicago, Illinois, when the legal purchase of needles required a medical prescription; a control group was recruited from an area with no NEP (reducing selection and dilution bias); participants were followed for up to 3 years; and the analyses included statistical controls for bias. In an earlier cross-sectional analysis, we found that regular use of the NEP was associated with lower levels of injection risk on nearly every measure. 20 In this report, we compare the injectionrelated risk behaviors of NEP users and nonusers over time and hypothesize that NEP users are likely to continue to exhibit lower levels of injection risk.
METHODS

Study Setting
The study setting and design have been described in detail elsewhere. 20 The NEP evaluated in this study was founded in 1996 through a collaboration between a community-based group, Chicago Health Outreach, and the University of Illinois at Chicago. The NEP operated legally and was funded by the Chicago Department of Public Health and the AIDS Foundation of Chicago. The NEP operated at 3 storefronts and a motor-home. One office offered NEP 5 days a week, 7 hours per day, whereas the other sites offered NEP 4 days a week, 2 hours per day. Needles were exchanged 1-for-1 except for the first 5 needles per visit, which were exchanged 2-for-1. No limit existed on the number of needles that could be exchanged. All NEP sites conducted individual risk assessments and provided other risk reduction materials. A mostly indigenous staff at the storefront offices offered other services, including HIV counseling and testing, case management, and referrals to offsite services such as drug treatment programs, and medical care was provided for persons living with HIV.
No NEP served the Southeast Side of Chicago until 2002, after the conclusion of data collection, when resources became available. Neighborhoods vary across the Southeast Side, as they do in the areas with NEPs, but for any particular community demographic characteristic, the Southeast Side resides within the range found at the NEP sites.
Study Design
Between 1997 and 2000, 901 adult IDUs were enrolled from the aforementioned sites into a prospective cohort study. All participants, except those from the South Side, were monitored at enrollment and 3 follow-up visits separated by 12 months. South Side participants were administrated only 1 follow-up visit, because this site was added 1 year later in the study. We recruited 681 NEP users at the NEP sites. Less than 10% of eligible NEP participants declined enrollment, most of whom said they lacked time to do the interview.
A control group of Southeast Side IDUs (n = 220) without local access to an NEP were recruited in street settings and through chain referral sampling. [21] [22] [23] Indigenous outreach workers initiated recruiting by contacting IDUs in a variety of Southeast Side congregation areas. To reduce sampling bias from outreach workers recruiting only IDUs who they knew or liked, we encouraged persons contacted on the street and all control group study participants to refer eligible persons to the study.
Control group members received standard-of-care HIV prevention services. All received HIVeducation; client-centered risk reduction counseling and HIV testing; prevention materials, including bleach, clean cookers, and condoms; and referrals to offsite services. Consistent with the study's longitudinal design, outreach staff spent much of their time in Southeast Side neighborhoods maintaining contact with study participants and, while doing so, promoting HIV risk reduction in a manner consistent with the National Institute on Drug Abuse Community-Based Outreach Model 24 and our own Indigenous Leader Outreach Model. 25 These methods have been associated with large declines in injection risk practices. 26, 27 Eligible study participants had to have injected drugs in the 6 months preceding the baseline interview, to speak English or Spanish, and to be at least 18 years old. Participants in our earlier National AIDS Demonstration Project (NADR) study were excluded because of the low levels of HIV risk practices that they exhibited subsequent to that intervention. 26 Age was verified through photograph-accompanied identification. Injection was verified through voluntary inspection for injection stigmata and, if that was inconclusive, verbal assessment by indigenous staff of the potential participant's familiarity with injection practices. Participants recruited as NEP users were required to have used the NEP at least twice ever and to have been enrolled in the NEP for at least 30 days. Participation in the NEP was verified by checking its records.
After obtaining informed signed consent, interviewers administered a standardized face-to-face interview in a private area, followed by pretest counseling and a blood draw for HIV testing. Specimens repeatedly reactive in whole-virus lysate enzyme-linked immunosorbent assays were confirmed by Western blot analysis. Participants were compensated $25 and given appointments to receive their HIV test results and posttest counseling. The same data collection procedure was used at follow-up visits. The study protocol and written informed consent were approved in advance by the Institutional Review Board at the University of Illinois at Chicago.
Measures
We compared IDUs who used an NEP, by personally attending an NEP or receiving needles from others who went to an NEP, with those who did not use an NEP in the 6 months before the baseline interview. This approach is conservative because it includes a subset of IDUs (n = 48), most of whom were frequent injectors, who enrolled at the control site but used an NEP in other communities.
We examined 5 injection-related risk behaviors as outcome variables. Receptive needle sharing was defined as injecting with a needle used by another person. Lending used needles was defined as providing a used needle to another IDU. Because using cookers, cotton filters, or rinse water with or after other people was highly correlated, we created a derivative variable, ''sharing other injection paraphernalia,'' to indicate sharing of any single item. Needle reuse was defined as a response greater than 1 to the question, ''Once you begin using a needle that belongs to you, how many hits do you usually use it for?'' Because IDUs often discount HIV risk behaviors involving a partner with whom they are close, such as a spouse or lover, respondents were encouraged to include such instances in their reports. Finally, among persons who shared needles receptively, we examined the proportion of IDUs who always cleaned a used needle with bleach. To minimize recall bias regarding sharing injection equipment, we used a 30-day recall period for receptive needle sharing, sharing other injection paraphernalia, and bleaching needles and a 6-month recall period for lending needles. No time period was specified for needle reuse, although the question implied current practice. Risk behaviors were originally assessed as ordinal response categories or continuous frequencies and were dichotomized to calculate prevalence rates in the analysis.
Baseline measures examined as potential confounders and predictors included age, gender, race/ethnicity, education, married/common law relationship, homelessness, main source of income (eg, regular job, other sources) in the past 6 months, monthly income, HIV status, and injection duration; other baseline measures examined over the past 6 months included injecting heroin, cocaine, or speedball (a mix of heroin and cocaine); smoking crack cocaine; injection frequency, group injection (injecting with others regardless of whether equipment was shared); injecting in semipublic settings (abandoned buildings, streets, alleys, parks, taverns, public restrooms, and cars); using a shooting gallery; having a sex partner who injects drugs; and receiving drug treatment. Injection frequency for the past 6 months was calculated as the product of the number of days during which drugs were injected and the typical number of injections per day.
Statistical Analysis
To test whether NEP users and nonusers are comparable, continuous variables at enrollment were compared using a t test or a Wilcoxon rank sum test. Categorical variables at baseline were compared between the 2 groups using x 2 tests or Fisher exact tests. A classic logistic regression model was used to examine the predictors for loss to follow-up and to test the assumption of missing completely at random. 28 We analyzed injection-related risk behaviors using random-effects logistic regression models to account for correlation among repeated measurements within subjects. 28 Specifically, the intercept was allowed to vary across subjects in the logistic regressions. First, we examined whether there were interactions between the study group (0 = NEP nonusers, 1 = NEP users) and visit time (linear and quadratic terms), after adjusting for age; gender; race/ethnicity; homelessness; injection frequency; injecting heroin or cocaine with others, in a shooting gallery, and in semipublic settings; smoking crack cocaine; having a sex partner who is an IDU; and baseline HIV status. Linear and quadratic terms are included because the prevalence of risk behaviors may decrease initially and level off later. Second, we removed nonsignificant interaction terms and covariates using a backward variable selection procedure that always included the study group variable. The final models only included variables that were significant (P , 0.05) or close to significant (P , 0.10). The models were estimated for each injection-related risk behavior separately. Only subjects who shared needles were included in the model of needle bleaching.
To have a population-averaged interpretation, we transformed the obtained regression coefficients and SEs to marginalized odds ratios (ORs) and corresponding 95% confidence intervals (CIs). 28 
RESULTS
Of 901 study participants, 729 (80.9%) reported using an NEP in the 6 months before their baseline interview (including 48 recruited in the control group area) and 172 (19.1%) indicated that they were NEP nonusers, all of whom were recruited in the control group area. At baseline, NEP users had participated in the program for an average of 12 months (interquartile range: 4-36 months). Baseline characteristics of NEP users and nonusers are summarized in Table 1 . NEP users were approximately 3 years younger than nonusers and had injected for shorter periods, but they injected more frequently than nonusers. No significant differences were observed between the 2 groups with respect to gender, race/ethnicity, marital status, education, sexual orientation, main source of income, or the injection of cocaine by itself. NEP users were less likely to consider themselves homeless and more likely to have a monthly income of at least $1000, to inject speedball, and to recently have been in drug treatment. NEP users were more likely to be HIV-positive, which was expected because NEPs were intentionally placed in neighborhoods known to have the highest HIV prevalence levels among IDUs. Most study participants injected heroin, particularly NEP users. During follow-up, interview data were collected from 740 (82.1%) study participants. The follow-up rate was slightly higher in NEP users (83.7%) than in nonusers (75.6%). More importantly, there were no significant differences between those followed and those not followed in all 5 injection-related risk behaviors measured at baseline. Figure 1 shows the prevalence of injection risk behaviors across 4 study visits separated by 1 year. The prevalence of receptive needle sharing 30 days before interview decreased from 47% at baseline to 20% at visit 4 in NEP nonusers and from 28% to 10% in NEP users. Figure  1A shows that the reduction was greatest between baseline and the first follow-up and then began leveling. The trend of decrease was nearly parallel between the 2 groups over time. A similar pattern was observed for lending used needles to others. At baseline, the 30-day prevalence of sharing cookers, cotton filters, or water was high in both groups, although greater in NEP nonusers than in NEP users, and it decreased dramatically during follow-up in both groups to nearly identical levels. At baseline, the prevalence of reusing one's own needle was lower in NEP users than in nonusers, and it decreased during study period, although patterns differed. The decline for NEP nonusers was slow at first but accelerated, whereas for NEP users, needle reuse decreased quickly and then slowly increased. Among IDUs who reused their needles, the median number of injections per needle was 3 across the 4 visits for NEP users and 5 for NEP nonusers. Finally, the use of bleach to clean needles was greater among NEP users at baseline, and there was no consistent change in its prevalence over time.
In the multivariate models, including the interaction between study group and time, none of the outcome variables except needle reuse (x 2 = 6.13, df = 2, P = 0.047) exhibited significant group-by-time interactions. In the final models, we removed the group-by-time interaction terms and other covariates that were not significant. Table 2 presents the marginalized ORs and 95% CIs calculated from the final models. Relative to NEP nonusers, NEP users were less likely to share needles receptively (OR = 0.33), pass used needles (OR = 0.55), and share other injection paraphernalia (OR = 0.70) across the 4 study visits. NEP users were also more likely than NEP nonusers always to bleach needles used by others (OR = 2.28). At baseline, NEP use was associated with an approximately 80% decreased odds of needle reuse. During follow-up, NEP users experienced a decelerated decreasing trend, whereas NEP nonusers had an accelerated reduction, although not statistically significant, in the prevalence of needle reuse. NEP use was still negatively associated with needle reuse after 3 years of follow-up (OR = 0.40, 95% CI: 0.21 to 0.74), however. Overall, there were significant decreases in receptive needle sharing, lending used needles, and the sharing other injection paraphernalia, although the rates of changes were decelerated. No significant trend was observed in the prevalence of needle bleaching.
Older IDUs were less likely to share needles receptively and to reuse their own needles but were more likely to share other injection paraphernalia. Women were less likely than men to reuse their needles. African Americans were at significantly lower risk for all injection-related behaviors except sharing other injection paraphernalia compared with whites and for needle sharing compared with Latinos. Frequent injection was associated with receptive needle sharing and sharing other paraphernalia when adjusted in the final models for the type of drug used. Injecting heroin was a strong predictor of almost all risk practices. In comparison, cocaine smoking and injecting were independent predictors of fewer sharing behaviors, and the strength of associations was weaker. Injecting with others was associated with receptive needle sharing and strongly associated with sharing other injection paraphernalia. Injecting in semipublic settings was associated with all risk behaviors. Because homeless IDUs were more likely to inject in semipublic settings, homelessness was not an independent predictor for sharing behaviors. Injecting in a shooting gallery was a risk factor for sharing needles and other paraphernalia. Participants with an IDU sex partner were also more likely to engage in almost all forms of 
DISCUSSION
This study demonstrates that compared with nonusers, NEP users engaged in less HIV-related injection risk. This difference persisted over time despite the exposure of NEP nonusers to indigenous street outreach, which was associated with large reductions in HIV risk in an earlier study that we conducted. 26 With dilution and selection bias kept to a minimum, the study provided strong evidence that NEPs are effective in reducing HIV risk behaviors. We did not observe group-by-time interactions in 4 outcomes, and most risk behaviors decreased in both groups. This decline in injection risk practices was most likely the result of participants being exposed to risk reduction promotion by indigenous staff, HIV counseling and testing, and participation in the study itself. 29 Risk reduction materials such as bleach, clean cotton filters, and water; condoms; and educational literature were made available to all participants. In addition, as street outreach workers recruited and followed participants in the control group, they were, in effect, delivering an HIV prevention intervention at the social network level. 25 Studies of network-level approaches have reported large declines in HIV injection risk practices, in part, by promoting the formation of group-level norms that support risk reduction. 26, 30, 31 Of the 3 sharing behaviors examined, the largest difference between NEP users and nonusers occurred in the riskiest injection behaviors: receptive needle sharing and lending used needles. The smallest difference was in sharing paraphernalia other than needles; however, this difference is notable in that studies often find no such associations. [32] [33] [34] We were unable to measure the extent to which making these items available at the NEP and through street outreach was associated with the observed decline in sharing.
Although compared with nonusers, NEP users were significantly less likely to reuse their own needles and to reuse them more than once, most (60%) engaged in this practice. An optimal public health goal for those who continue to inject drugs is to use a sterile needle for every injection to avoid serious bacterial infections that incubate in used needles and viral infections that occur when a needle is used by others without knowledge of its owner. The prevalence of needle reuse we found among NEP participants is nearly identical to that reported in a California study for NEPs with similar 1-for-1-plus exchange policies but higher than for NEPs that determine the number of needles they provide based on an assessment of the client's need. 35 Even at NEPs with needbased exchange policies, 37% of users reported recent needle reuse. 35 Placing a greater emphasis through education and counseling on eliminating needle reuse may further reduce this practice, but the circumstances of illicit drug injection virtually guarantee its existence at some minimal level. 36, 37 Still, the prevalence of needle reuse among clients of NEPs with needbased exchange policies was almost half that of 1-for-1 NEPs, and our own study found that the frequency of reuse was much lower among NEP users compared with nonusers. Taken together, these findings indicate that needle reuse is likely to decline markedly when IDUs have adequate supplies of new sterile needles.
Several limitations need to be considered when interpreting the results. Behaviors were self-reported in this longitudinal study and may be subject to recall bias. To minimize inaccuracy in reporting, we asked about the past 30 days when examining receptive needle sharing and the sharing of other injection paraphernalia. Socially desirable reporting may have occurred. Responses to follow-up interviews may be influenced by previous counseling, such that the observed reductions in risk behaviors are not true. Not all risk behaviors decreased, however, and the magnitudes of reduction were not the same, suggesting that the large reductions in the sharing of needles and other paraphernalia were true behavioral changes. We believe that NEP users and nonusers had a similar propensity to report stigmatized behaviors, because both groups were exposed to HIV education and risk reduction counseling.
Sizable numbers of study participants did not return for follow-up interviews, which compromised analytic efficiency. Attrition analysis showed that there were no significant differences between those followed and those not followed in baseline injection-related risk behaviors, however, suggesting that the results were unlikely to be biased because of selective loss to follow-up. The extent that study findings can be generalized to other populations of IDUs is unknown. Participants were not randomly selected, and we cannot say with any certainty how they compare with the general population of IDUs. Conversely, our study design and use of statistical adjustment minimized systematic biases between the NEP users and nonusers; thus, valid inferences can be reached.
Keeping these limitations in mind, our study suggests that NEPs can help to reduce injection-related risk behaviors in communities with no reliable access to sterile needles and that the reduction can persist for a long time. The large decline in most risk practices exhibited by the control group of NEP nonusers is consistent with findings from a multitude of earlier studies 27, 38 showing that behavioral interventions alone can have a considerable impact on reducing injection risk practices. This study documents an additional impact of NEP over strictly behavioral efforts at injection risk reduction, and the addition is particularly notable for the risk practice that carries the greatest likelihood of transmitting HIV-receptive needle sharing. Given these impacts, NEPs stand as a necessary component of a comprehensive strategy for maximizing the prevention of HIV and other bloodborne pathogens.
